Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients

被引:2
|
作者
Stanciu, Adina Elena [1 ]
Zamfir-Chiru-Anton, Adina [2 ]
Stanciu, Marcel Marian [3 ]
Gherghe, Mirela [4 ,5 ]
Hainarosie, Razvan [6 ,7 ]
Furtunescu, Florentina Ligia [8 ]
Gheorghe, Dan Cristian [7 ,9 ]
机构
[1] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Carcinogenesis & Mol Biol, 252 Fundeni St, Bucharest 022328, Romania
[2] Grigore Alexandrescu Childrens Emergency Hosp, ENT Dept, Bucharest 011743, Romania
[3] Politehn Univ, Elect Engn Fac, Bucharest 060042, Romania
[4] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Nucl Med, Bucharest 022328, Romania
[5] Carol Davila Univ Med & Pharm, Dept Radiol, Bucharest 050463, Romania
[6] Prof Dr Dorin Hociota Inst Phonoaudiol & Funct EN, ENT Dept, Bucharest 050751, Romania
[7] Carol Davila Univ Med & Pharm, ENT Dept, Bucharest 050463, Romania
[8] Carol Davila Univ Med & Pharm, Dept Complementary Sci, 37 Dionisie Lupu St, Bucharest 050463, Romania
[9] Maria Sklodowska Curie Childrens Emergency Hosp, ENT Dept, Bucharest 077120, Romania
关键词
burn injury; biomarkers; MMP-9; TIMP-1; ratio; THERMAL-INJURY; SKIN; HYPERPERMEABILITY; MELATONIN; SEVERITY; MMP-9;
D O I
10.3892/etm.2021.10496
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Burn injuries can trigger tissue changes that can explain the variation in the level of different biochemical markers that can be recorded both locally or systemically. Some events observed in burn wounds such as vascular hyperpermeability have been associated with the release of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) after trauma. Because it is unknown whether the serum levels of MMP-9 and TIMP-1 are a consequence of these destructions or a local response to thermal damage, we decided to follow their dynamics. Twenty-five patients (mean age 49.40 +/- 17.55 years) with a total body surface area (TBSA) affected by a thermal burn of <25% and 30 healthy subjects (mean age 49.70 +/- 8.04 years) were enrolled in the present study. Enzyme immunoassays were used to measure the serum levels of MMP-9 and TIMP-1. Our results showed that MMP-9 was increased 6.25-fold immediately after injury compared to the controls and remained on a plateau throughout the 7-day monitoring period. TIMP-1 showed an upward trend with an increase of 49.52% on the seventh day after triggering insult. The time-course of the MMP-9/TIMP-1 ratio followed the inverse dynamics of TIMP-1 starting from a ratio value measured at admission 3.82-fold higher than the one observed in the healthy volunteers and a highly statistically significant correlation between the values measured at different time-points during the monitoring period (P<0.001). The results of this retrospective study indicate that the MMP-9/TIMP-1 ratio may provide information on local changes over time, starting from the triggering insult, and may be considered as a predictive biomarker of burn evolutivity.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
    Bojic, Suzana
    Kotur-Stevuljevic, Jelena
    Aleksic, Aleksandra
    Gacic, Jasna
    Memon, Lidija
    Simic-Ogrizovic, Sanja
    DISEASE MARKERS, 2018, 2018
  • [42] Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion
    Tanindi, Asli
    Sahinarslan, Asife
    Elbeg, Sehri
    Cemri, Mustafa
    CORONARY ARTERY DISEASE, 2011, 22 (04) : 253 - 258
  • [43] Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2
    Zhou Shao-fei
    Hu San-yuan
    Ma Lei
    Miao Lei
    Mao Wei-zheng
    CHINESE MEDICAL JOURNAL, 2013, 126 (10) : 1925 - 1929
  • [44] Matrix metalloproteinase-2, -9 and tissue inhibitor metalloproteinase-1 in patients with hypertension before and after doxazosin therapy
    Derosa G.
    Cicero A.F.G.
    D'Angelo A.
    Tinelli C.
    Ciccarelli L.
    Piccinni M.N.
    Pricolo F.
    Salvadeo S.
    Montagna L.
    Fogari E.
    Gravina A.
    Ferrari I.
    Galli S.
    Paniga S.
    Fogari R.
    High Blood Pressure & Cardiovascular Prevention, 2006, 13 (2) : 47 - 52
  • [45] Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis
    Palus, Martin
    Zampachova, Eva
    Elsterova, Jana
    Ruzek, Daniel
    JOURNAL OF INFECTION, 2014, 68 (02) : 165 - 169
  • [46] Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome
    Bertsch, T
    Sueselbeck, T
    Wolpert, C
    Hoffmann, U
    Kaden, JJ
    Haase, KK
    Borggrefe, M
    Brueckmann, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (06) : 660 - 663
  • [47] IVIg decreases matrix metalloproteinase-9 production, not tissue inhibitor of metalloproteinase-1, by PBMC of multiple sclerosis patients
    Okada, K.
    Tsuji, S.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 209 - 210
  • [48] Enhanced Exhalation of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients with COPD Exacerbation: A Prospective Study
    Kwiatkowska, S.
    Noweta, K.
    Zieba, M.
    Nowak, D.
    Bialasiewicz, P.
    RESPIRATION, 2012, 84 (03) : 231 - 241
  • [49] Serum matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 and heart remodeling in patients with aortic stenosis after operation
    Goncharova, N.
    Moiseeva, O.
    Aleshina, G.
    Shlyakhto, E.
    JOURNAL OF HYPERTENSION, 2007, 25 : S45 - S45
  • [50] Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
    Rubanenko, O.
    Shchukin, Y.
    Rubanenko, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 284 - 284